Desjardins Global Asset Management’s Zimmer Biomet ZBH Stock Holding History

Desjardins Global Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$2.05M	Buy	16,823 +181	+1%	+$20.2K	0.22%	109
2023 Q3	$1.87M	Buy	16,642 +10,252	+160%	+$1.3M	0.2%	110
2023 Q2	$930K	Buy	6,390 +160	+3%	+$21.7K	0.11%	192
2023 Q1	$805K	Sell	6,230 -138	-2%	-$17.3K	0.1%	179
2022 Q4	$811K	Buy	6,368 +416	+7%	+$48.3K	0.13%	167
2022 Q3	$622K	Sell	5,952 -92	-2%	-$10.1K	0.08%	205
2022 Q2	$634K	Buy	6,044 +804	+15%	+$95.4K	0.08%	204
2022 Q1	$670K	Sell	5,240 -144	-3%	-$17.4K	0.06%	230
2021 Q4	$664K	Buy	+5,384	New	+$705K	0.06%	248

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Desjardins Global Asset Management's ZBH Position: Q4 2023 in Review

Desjardins Global Asset Management increased its Zimmer Biomet (ZBH) stake by 1.1% in Q4 2023, buying an estimated $20.2K and bringing the position to 16,823 shares worth $2.05M. The position accounts for 0.22% of the portfolio, ranked #109.

Desjardins Global Asset Management first reported a position in ZBH in Q4 2021 and has held it in 9 quarters since. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

Desjardins Global Asset Management held 16,823 shares of Zimmer Biomet worth $2.05M as of Q4 2023.
Desjardins Global Asset Management bought 181 Zimmer Biomet shares in Q4 2023, an estimated $20.2K.
Zimmer Biomet made up 0.22% of Desjardins Global Asset Management's portfolio in Q4 2023, its #109 holding.
Desjardins Global Asset Management first reported a position in Zimmer Biomet in Q4 2021 and has held it in 9 quarters since.
1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.